Therefore, we created a Tr1 score based on our previously published data (16) and found that the IL-10–producing Foxp3–CD4+ T cells in NASH had a lower Tr1 score compared with those in the liver of NAFLD patients (Supplemental Figure 3C). Here, FOXP3 is linked to metabolic dysfunction-associated steatotic liver disease.